```html

Yellowish Discoloration of the Sclera (Jaundice of the Eyes)

What is Yellowish Discoloration of the Sclera?

Yellowish discoloration of the sclera—often simply called “yellow eyes”—refers to a pale‑yellow tint that appears on the white part of the eye (the sclera). The sclera normally looks bright white because it is covered by a clear layer of conjunctiva. When bilirubin, a breakdown product of red blood cells, builds up in the bloodstream, it can deposit in tissues that have a rich blood supply, including the sclera. The visual change is usually one of the first, most noticeable signs of jaundice, a symptom rather than a disease.

While the change itself is harmless, it signals that something is altering the normal processing of bilirubin in the liver, gallbladder, or red blood cells. Understanding why the sclera becomes yellow helps clinicians pinpoint potentially serious underlying conditions.

Common Causes

Yellowing of the sclera can stem from a wide range of conditions. Below are the most frequently encountered causes, organized by the primary organ system involved.

• Hepatocellular disease (liver injury) – acute or chronic hepatitis (A, B, C, alcoholic, non‑alcoholic fatty liver disease).
• Biliary obstruction – gallstones, strictures, or tumors blocking bile flow (e.g., choledocholithiasis, cholangiocarcinoma).
• Hemolysis – accelerated breakdown of red blood cells (e.g., sickle cell disease, G6PD deficiency, autoimmune hemolytic anemia).
• Genetic disorders – Gilbert’s syndrome or Crigler‑Najjar syndrome, both affecting bilirubin conjugation.
• Medication‑induced jaundice – drugs such as acetaminophen overdose, certain antibiotics (e.g., ceftriaxone), and statins.
• Pancreatic cancer – especially tumors at the head of the pancreas that compress the bile duct.
• Liver cirrhosis – scarring from chronic liver disease reduces bilirubin clearance.
• Sepsis or severe infection – can trigger cholestasis (reduced bile flow) even without overt liver disease.
• Newborn physiologic jaundice – common in the first week of life; usually harmless but requires monitoring.
• Inherited metabolic disorders – such as Dubin‑Johnson syndrome, where conjugated bilirubin accumulates.

Associated Symptoms

Yellow sclera rarely appears in isolation. Look for other signs that can help narrow down the cause.

• Skin discoloration – a yellow hue on the skin, especially on the face and abdomen (true jaundice).
• Dark urine – bilirubin excreted in urine makes it appear amber or tea‑colored.
• Pale or clay‑colored stools – indicates lack of bile pigment in the gastrointestinal tract.
• Abdominal pain or fullness – often right‑upper‑quadrant pain from gallbladder or liver disease.
• Pruritus (itching) – bile salts depositing in skin can cause severe itching.
• Fatigue, weakness, or loss of appetite – common with chronic liver disease.
• Fever, chills, or night sweats – suggest infection or malignancy.
• Weight loss – may accompany cancer or advanced liver disease.
• Swelling of the abdomen or legs (ascites, edema) – indicates advanced liver dysfunction.

When to See a Doctor

Because yellow sclera can signal serious systemic illness, prompt medical evaluation is important whenever any of the following occur:

• Yellowing persists for more than 24‑48 hours or worsens.
• Accompanied by dark urine, pale stools, or itching.
• Severe abdominal pain, especially in the upper right quadrant.
• Unexplained fever, chills, or rapid weight loss.
• History of liver disease, gallstones, or hemolytic anemia.
• Recent use of medications known to affect the liver (e.g., acetaminophen >4 g/day, certain antibiotics).
• Newborns develop yellow eyes within the first 24 hours of life or the yellowing spreads rapidly.

Diagnosis

Evaluation begins with a thorough history and physical exam, followed by targeted laboratory and imaging studies.

1. History & Physical Examination

• Onset, duration, and progression of yellowing.
• Alcohol intake, medication list, recent travel, and family history of liver disease.
• Physical signs: hepatomegaly, splenomegaly, ascites, tenderness, or skin lesions.

2. Laboratory Tests

• Serum bilirubin – total, direct (conjugated) and indirect (unconjugated) levels help differentiate causes.
• Liver function panel – ALT, AST, ALP, GGT, and albumin.
• Complete blood count (CBC) – assesses anemia or infection.
• Hemolysis work‑up – LDH, haptoglobin, reticulocyte count, peripheral smear.
• Viral serologies – hepatitis A, B, C, and sometimes EBV or CMV.
• Autoimmune markers – ANA, ASMA, anti‑LKM if autoimmune hepatitis is suspected.

3. Imaging Studies

• Abdominal ultrasound – first‑line for gallstones, biliary duct dilation, liver morphology.
• CT or MRI – detailed view of pancreas, liver masses, or biliary tree.
• MRCP (Magnetic Resonance Cholangiopancreatography) – non‑invasive imaging of bile ducts.
• Endoscopic Retrograde Cholangiopancreatography (ERCP) – diagnostic and therapeutic for obstructive lesions.

4. Specialized Tests

• Genetic testing for Gilbert’s, Crigler‑Najjar, Dubin‑Johnson syndromes when hereditary causes are suspected.
• Liver biopsy – rarely needed but may be performed for unclear chronic liver disease.

Treatment Options

Treatment is directed at the underlying cause; the scleral yellowing will resolve as bilirubin levels normalize.

1. Hepatocellular Injury

• **Acute viral hepatitis** – supportive care (rest, hydration); antiviral therapy for hepatitis B or C as indicated (e.g., entecavir, sofosbuvir/velpatasvir).
• **Alcohol‑related liver disease** – abstinence, nutritional support, corticosteroids for severe alcoholic hepatitis.
• **Non‑alcoholic fatty liver disease** – weight loss (7‑10 % body weight), exercise, control of diabetes/lipids.

2. Biliary Obstruction

• **Gallstones** – endoscopic removal (ERCP) or surgical cholecystectomy.
• **Tumors** – oncologic treatment (surgery, chemotherapy, targeted therapy) and biliary stenting to relieve obstruction.
• **Strictures** – dilatation and stent placement via ERCP.

3. Hemolytic Disorders

• **Transfusion‑related or drug‑induced hemolysis** – discontinue offending agent, transfuse if needed.
• **Inherited hemolysis** – folic acid supplementation, hydroxyurea for sickle cell disease, avoidance of triggers.
• **Autoimmune hemolytic anemia** – steroids, rituximab, or splenectomy in refractory cases.

4. Genetic Syndromes

• **Gilbert’s syndrome** – usually requires no treatment; avoid fasting, dehydration, and certain drugs that increase bilirubin.
• **Crigler‑Najjar type II** – phenobarbital can lower bilirubin; liver transplant for severe type I.

5. Symptomatic & Supportive Measures

• Adequate hydration to support renal clearance of bilirubin.
• Phototherapy for severe neonatal jaundice (blue‑light therapy).
• Pruritus control – cholestyramine, antihistamines, or rifampin for severe itching.

6. Home Care While Awaiting Evaluation

• Maintain a balanced diet low in saturated fat and high in fruits/vegetables.
• Avoid alcohol and limit over‑the‑counter pain relievers (especially acetaminophen) until a cause is identified.
• Stay well‑hydrated (≥2 L water/day) unless fluid restriction is prescribed.

Prevention Tips

Many causes of yellow sclera are modifiable. Incorporate these habits to reduce risk:

• Limit alcohol consumption – no more than 1 drink/day for women, 2 for men.
• Vaccinate against hepatitis A and B.
• Practice safe sex and avoid needle sharing to reduce hepatitis C risk.
• Maintain a healthy weight – reduces non‑alcoholic fatty liver disease.
• Stay active – at least 150 minutes of moderate exercise per week.
• Read medication labels – avoid excessive acetaminophen and discuss herbal supplements with a clinician.
• Promptly treat gallstone disease – seek care for right‑upper‑quadrant pain or biliary colic.
• Screen for hereditary conditions if you have a family history of liver or hemolytic disorders.

Emergency Warning Signs

Bottom Line

Yellowish discoloration of the sclera is a visible clue that bilirubin metabolism is disrupted. While the eye change itself is harmless, it often heralds liver, biliary, or blood‑cell problems that may require urgent attention. Recognizing accompanying symptoms, seeking timely medical evaluation, and addressing underlying risk factors are the keys to preventing complications and restoring the eyes—and the body—to health.

For more detailed information, consult trusted sources such as the Mayo Clinic, CDC, NIH, WHO, and the Cleveland Clinic.

```